Connect Biopharma Holdings Limited
CNTB
$0.7901
-$0.0099-1.24%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 19.78% | 0.22% | -17.48% | -21.53% | -25.83% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | 45.96% | 46.04% | 63.79% | 100.00% |
| Total Operating Expenses | -29.79% | -35.71% | -40.84% | -41.73% | -43.00% |
| Operating Income | 67.49% | 67.21% | 67.33% | 53.16% | 43.00% |
| Income Before Tax | 75.15% | 74.18% | 73.78% | 59.55% | 49.39% |
| Income Tax Expenses | 85.83% | -9.65% | -54.83% | -57.95% | -60.87% |
| Earnings from Continuing Operations | 74.84% | 74.02% | 73.72% | 59.55% | 49.42% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 74.84% | 74.02% | 73.72% | 59.55% | 49.42% |
| EBIT | 67.49% | 67.21% | 67.33% | 53.16% | 43.00% |
| EBITDA | 68.11% | 67.76% | 67.81% | 53.49% | 43.24% |
| EPS Basic | 74.98% | 74.10% | 73.75% | 59.57% | 49.44% |
| Normalized Basic EPS | 75.26% | 73.97% | 73.31% | 58.10% | 47.41% |
| EPS Diluted | 74.85% | 73.91% | 73.53% | 59.39% | 49.28% |
| Normalized Diluted EPS | 75.18% | 73.90% | 73.25% | 58.07% | 47.41% |
| Average Basic Shares Outstanding | 0.27% | 0.20% | 0.14% | 0.09% | 0.04% |
| Average Diluted Shares Outstanding | 0.64% | 0.57% | 0.51% | 0.28% | 0.04% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |